通过SrTiO3纳米弹性催化剂实现的Sono-Flexocatalytic瘤抑制
Yanjia Lu1,2, Jian Lu3, Mengying Hua3
1School of Medicine, Nanjing Medical University, Nanjing, 210009, P.R. China.
Angewandte Chemie (International ed. in English)
|December 31, 2025
概括
这项研究引入了使用酸 (SrTiO3) 纳米催化剂的声灵活催化疗法 (SFT). 通过超声波诱导的柔电,通过产生反应性氧物种 (ROS),SFT有效地治疗瘤,克服了传统焦催化方法的局限性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 压触媒式瘤疗法显示出前景,但需要非中心对称的催化剂.
- 中心对称材料,如酸 (SrTiO3),通常不适合这样的应用.
- 需要一种新的方法来利用易于获得的中心对称材料进行非侵入性瘤治疗.
研究的目的:
- 开发一种使用中心对称SrTiO3纳米催化剂的新型声灵活催化疗法 (SFT) 策略.
- 为了克服传统的焦催化瘤治疗的物质限制.
- 通过超声波诱导的柔性电力来证明SFT在抑制瘤生长中的有效性.
主要方法:
- 使用的中心对称酸 (SrTiO3) 纳米催化剂.
- 应用超声波辐射来诱导SrTiO3.3中的应变梯度和柔电极化.
- 研究了活性氧物种 (ROS) 的生成及其对瘤细胞的细胞毒性作用.
- 通过体外和体外瘤模型验证了SFT策略.
- 采用理论模拟来阐明声波-弹性催化机制.
主要成果:
- 对SrTiO3的超声波辐射产生了显著的柔电极化和电荷分离.
- 这一过程导致了瘤细胞内大量的细胞毒性ROS (基激素,超氧化离子) 的产生.
- 诱导的氧化应激导致线粒体功能障碍和亡,有效抑制瘤生长.
- 在体外和体内研究证实了SFT的治疗疗效.
- 理论模拟澄清了依赖应变梯度的柔性催化机制.
结论:
- 声波柔性催化疗法 (SFT) 提供了一种新的非侵入性治疗方式,用于使用中心对称的SrTiO3纳米催化剂治疗瘤.
- 在SrTiO3中超声触发的柔电有效地产生用于癌症治疗的ROS.
- 这项工作扩大了中心对称生物材料在声触媒治疗中的适用性,并为全触媒医学建立了新的范式.
相关概念视频
01:07Catalytically Perfect Enzymes
4.9K
The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Most enzymes...
Most enzymes...
4.9K
02:50Catalysis
30.0K
The presence of a catalyst affects the rate of a chemical reaction. A catalyst is a substance that can increase the reaction rate without being consumed during the process. A basic comprehension of a catalysts’ role during chemical reactions can be understood from the concept of reaction mechanisms and energy diagrams.
30.0K
02:47Ribozymes
3.3K
3.3K
02:47Ribozymes
13.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.2K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K